HCPlive (10/3, Derman) reports, “Antipsychotic dose reduction or discontinuation increases the risk of severe relapse in people with schizophrenia or other psychotic disorders,” investigators concluded in the findings of a 253-patient study published online Sept. 28 ahead of print in The Lancet Psychiatry. The study found that “gradually reducing antipsychotic dosage increases the risk of relapse for people with psychotic disorders and does not improve social functioning.”
Related Links:
— “Antipsychotic Dose Reduction or Discontinuation Can Lead to Severe Relapse,”Chelsie Derman, HCPlive, October 3, 2023